$ARIA Recent News Hewlett-Packard, a cyclical green light

New Post Public Reply Private Reply Replies (0) Message Board

Dec 1, 2013 at 1:15 PM

$ARIA Recent News

Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy

Benzinga's Top #PreMarket Losers 7:19 a.m. Nov. 29, 2013 - benzinga.com
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
Wednesday’s Biggest Stock Losers: BLOX, BRLI and More 5:10 a.m. Nov. 27, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) In A Perilous Reversal 11:50 a.m. Nov. 26, 2013 - TheStreet.com
Nuance and ARIAD Are Volume Movers for Very Different Reasons 11:24 a.m. Nov. 26, 2013 - 247WallSt.com
Ariad Pharma Appears Cheap Despite Reduced Opportunity 9:19 a.m. Nov. 26, 2013 - Seeking Alpha
Cramer's Lightning Round - What Happened With Ariad Was Jarring (11/25/13) 6:05 a.m. Nov. 26, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Splunk 6:00 a.m. Nov. 26, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market 8:25 p.m. Nov. 25, 2013 - TheStreet.com
Continuation of ARIAD's Iclusig in EU - Analyst Blog 5:00 p.m. Nov. 25, 2013 - Zacks.com
Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000 3:57 p.m. Nov. 25, 2013 - benzinga.com
ARIAD Shares Skyrocketing With 11 Positive Estimate Revisions 1:35 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:27 p.m. Nov. 25, 2013 - TheStreet.com
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock 12:36 p.m. Nov. 25, 2013 - TheStreet.com
3 Monday Morning Biotech Movers 12:15 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Strength Seen in Ariad Pharmaceuticals (ARIA): Stock Zooms 35.5% - Tale of the Tape 9:39 a.m. Nov. 25, 2013 - Zacks.com
Ariad Pharmaceuticals looks to extend Friday's rally 8:44 a.m. Nov. 25, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:12 a.m. Nov. 25, 2013 - benzinga.com
Mid-Afternoon Market Update: Markets on the Rise as Intel Falls 2:34 p.m. Nov. 22, 2013 - benzinga.com

Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
TrendingWallStreet.com Begins Market Coverage on NLY, VEND, ARIA, and FB 12:15 a.m. Nov. 27, 2013 - ACCESSWIRE
Must Watch Stocks: Ariad Pharmaceuticals, Hewlett-Packard Company, Camtek Ltd, Buka Ventures Inc 9:01 a.m. Nov. 26, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Analysis on BAC, NVGC, ARIA, and C 12:16 a.m. Nov. 26, 2013 - ACCESSWIRE
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 25, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Coverage on ARIA, TXCC, SFTBY, and TWC 1:38 a.m. Nov. 25, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. -- ARIA 3:32 p.m. Nov. 22, 2013 - GlobeNewswire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against ARIAD Pharmaceuticals, Inc. and Certain Officers - ARIA 8:00 a.m. Nov. 22, 2013 - PR Newswire
ARIAD Announces Positive Opinion by the European Medicines Agency on the Continued Availability of Iclusig in Patients with Leukaemias 7:46 a.m. Nov. 22, 2013 - BusinessWire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Must Watch News & Earnings: Tesla Motors Inc, Pan Global Corp, Ariad Pharmaceuticals, Alpha Natural Resources, Brocade Communications Systems 10:23 a.m. Nov. 19, 2013 - PR Newswire
Appointments, Financial Results, Divestitures, and Staff Reductions- Research Report on AstraZeneca, VIVUS, Cooper, ARIAD, and Amarin 8:00 a.m. Nov. 13, 2013 - PR Newswire
Stock Analysis Reports on AMD, ARIA and GSAT 1:20 a.m. Nov. 13, 2013 - ACCESSWIRE
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Nov. 12, 2013 - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Nov. 12, 2013 - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

CABP Market Sees Potential in New Treatments Rising

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Wooree Group Pushes for Rigorous Liposome Standards

Rallying for Rigorous Scientific Validation Ever find yourself pondering how many so-called 'innovative' health products really deliver what they promise? Let me tell ya, Wooree Group’s CEO, Ji-yong Yoon, ain’t buying into flimsy claims. At the Vitafoods Asia 2026 event in Bangkok, Yoon sent a clear message: Without scientific validation, calling a product 'liposomal'...

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Dentsply Sirona Faces Insider Troubles: An Investor Call

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

SKF's Automotive Arm Set for Stockholm Debut in Dec

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Stem Cell Market Set for Major Gains to 2031

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...